(Source: Progressive Osseous Heteroplasia; Genetic and Rare Diseases Information Center (GARD) of National Center for Advancing Translational Sciences (NCATS), USA.)
(Source: Progressive Osseous Heteroplasia; Genetic and Rare Diseases Information Center (GARD) of National Center for Advancing Translational Sciences (NCATS), USA.)
It is important to note that having a risk factor does not mean that one will get the condition. A risk factor increases one’s chances of getting a condition compared to an individual without the risk factors. Some risk factors are more important than others.
Also, not having a risk factor does not mean that an individual will not get the condition. It is always important to discuss the effect of risk factors with your healthcare provider.
The genetics of Progressive Osseous Heteroplasia (POH) is complex and may not yet be fully understood.
Progressive Osseous Heteroplasia (POH) is described as an autosomal dominant trait.
(Source: Progressive Osseous Heteroplasia; Genetic and Rare Diseases Information Center (GARD) of National Center for Advancing Translational Sciences (NCATS), USA.)
Autosomal dominant: Autosomal dominant conditions are traits or disorders that are present when only one copy of the mutation is inherited on a non-sex chromosome. In these types of conditions, the individual has one normal copy and one mutant copy of the gene. The abnormal gene dominates, masking the effects of the correctly function gene. If an individual has an autosomal dominant condition, the chance of passing the abnormal gene on to their offspring is 50%. Children, who do not inherit the abnormal gene, will not develop the condition or pass it on to their offspring.
Symptoms of Progressive Osseous Heteroplasia (POH) usually are apparent within the first few months of life, and may be present from birth.
The rate of progression also varies greatly among affected individuals and is unpredictable. However, most individuals experience a gradual progression of the condition.
Very frequently present symptoms in 80-99% of the cases:
Frequently present symptoms in 30-79% of the cases: Ectopic ossification in muscle tissue.
Occasionally present symptoms in 5-29% of the cases:
(Source: Progressive Osseous Heteroplasia; Genetic and Rare Diseases Information Center (GARD) of National Center for Advancing Translational Sciences (NCATS), USA.)
Progressive Osseous Heteroplasia (POH) must first be differentiated from nonhereditary causes of heterotopic ossification (HO) as well as other hereditary causes. POH is among several related genetic disorders, including Albright hereditary osteodystrophy (AHO), pseudohypoparathyroidism (PHP), and primary osteoma cutis, which share the common features of superficial ossification and association with mutations in the GNAS gene. These disorders are characterized by additional features that are not associated with POH.
POH is diagnosed on the basis of three major criteria:
In addition to these key diagnostic criteria, there are several findings that support the diagnosis of POH. These include:
(Source: Progressive Osseous Heteroplasia; Genetic and Rare Diseases Information Center (GARD) of National Center for Advancing Translational Sciences (NCATS), USA.)
Many clinical conditions may have similar signs and symptoms. Your healthcare provider may perform additional tests to rule out other clinical conditions to arrive at a definitive diagnosis.
The complications of Progressive Osseous Heteroplasia may include:
Complications may occur with or without treatment, and in some cases, due to treatment also.
At this time, there are no effective treatments or prevention for Progressive Osseous Heteroplasia (POH).
(Source: Progressive Osseous Heteroplasia; Genetic and Rare Diseases Information Center (GARD) of National Center for Advancing Translational Sciences (NCATS), USA.)
Currently, Progressive Osseous Heteroplasia may not be preventable, since it is a genetic disorder.
Genetic testing of the expecting parents (and related family members) and prenatal diagnosis (molecular testing of the fetus during pregnancy) may help in understanding the risks better during pregnancy
If there is a family history of the condition, then genetic counseling will help assess risks, before planning for a child
Active research is currently being performed to explore the possibilities for treatment and prevention of inherited and acquired genetic disorders
Regular medical screening at periodic intervals with tests and physical examinations are recommended.
Because Progressive Osseous Heteroplasia (POH) is so rare, there is limited information about long-term outlook (prognosis).
The progression of POH is highly variable even among members of the same family. In some individuals, it may progress extremely slowly; in others it may progress more rapidly
Most individuals experience a gradual progression of the condition. The degree of morbidity depends on the location and extent of abnormal bone formation, and in some cases, the condition results in severe disability
The condition may be associated with restricted movement of the arms and legs caused by "locking" of joints (ankyloses), pain, and secondary osteoporosis. POH may also restrict movement in the hips, jaw, shoulders, and/or other areas of the body
Despite the morbidity associated with POH, there is no known effect on the lifespan of affected individuals as it does not directly affect the internal organs
(Source: Progressive Osseous Heteroplasia; Genetic and Rare Diseases Information Center (GARD) of National Center for Advancing Translational Sciences (NCATS), USA.)
The following DoveMed website link is a useful resource for additional information:
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.